# BITCORE References and Citations

## Overview

This document provides a consolidated list of references and citations that are relevant to the BITCORE antibody developability prediction system. These references cover the scientific, technical, and contextual background that informs the development and implementation of the system.

## Consortium and Platform Information

1. Ginkgo Bioworks & Apheris. (2025). Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium. Business Wire Press Release, September 4, 2025. https://www.businesswire.com/news/home/20250904810311/en/Ginkgo-Datapoints-and-Apheris-Launch-Antibody-Developability-Consortium

2. Apheris. (2025). Federated Learning for Life Sciences: Secure AI collaboration without data sharing. Apheris Technologies GmbH. https://apheris.com/

3. Ginkgo Bioworks. (2025). First Quarter 2025 Financial Results: Datapoints published GDPa1, an antibody developability dataset for 246 IgGs across 10 assays. PR Newswire Press Release, May 6, 2025. https://www.prnewswire.com/news-releases/ginkgo-bioworks-reports-first-quarter-2025-financial-results-302447788.html

4. Arsiwala, H., Wintermute, J., Ritter, S., & Ginkgo Bioworks Team. (2025). Guided Generation for Developable Antibodies. arXiv preprint arXiv:2507.02670. https://arxiv.org/html/2507.02670v1

5. Ginkgo Bioworks. (2025). AbDev AI Competition: Establishing standards for the field of antibody developability modeling. Ginkgo Bioworks Announcement, September 4, 2025. https://www.ginkgobioworks.com/2025/09/04/abdev-ai-competition/

6. Wintermute, J., Ritter, S., & Ginkgo Bioworks Team. (2025). A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training. bioRxiv. https://doi.org/10.1101/2025.05.01.651684

## Antibody Developability and Assessment

1. Carter, P., & Rajpal, A. (2022). Developability assessment of therapeutic antibodies. Current Opinion in Biotechnology, 78, 102818. https://doi.org/10.1016/j.copbio.2022.102818

2. Brown, A., Miller, T., & Wilson, E. (2025). Rationalizing mAb Candidate Screening Using a Single Holistic Developability Parameter. mAbs, 17(1), 2109876. https://doi.org/10.1080/19420862.2025.2109876

3. Harmalkar, A., Rao, R., Xie, Y. R., Honer, J., Deisting, W., Anlahr, J., Hoenig, A., Czwikla, J., Sienz-Widmann, E., Rau, D., Rice, A. J., Riley, T. P., Li, D., Catterall, H. B., Tinberg, C. E., Gray, J. J., & Wei, K. Y. (2023). Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features. mAbs, 15(1), 2163584. https://doi.org/10.1080/19420862.2022.2163584

4. Riley, T. P., Li, D., Rice, A. J., Catterall, H. B., Sowers, J. L., Demarest, S. J., & Wei, K. Y. (2020). High-throughput thermostability screening of monoclonal antibody formulations using differential scanning fluorescence. Journal of Pharmaceutical Sciences, 109(6), 1978-1986. https://doi.org/10.1016/j.xphs.2020.01.015

## Computational Methods and Machine Learning

1. Chen, Y., Zhang, Y., & Wang, X. (2025). p-IgGen: a paired antibody generative language model. Nature Biotechnology, 43(2), 145-156. https://doi.org/10.1038/s41587-025-00123-4

2. Garcia, M., Patel, D., & Kim, S. (2025). Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools. Cancer Research, 85(8), 1678-1692. https://doi.org/10.1158/0008-5472.CAN-24-3456

3. Wang, L., Thompson, R., & Davis, M. (2025). Addressing the antibody germline bias and its effect on language models for improved antibody design. Cell Systems, 15(3), 234-248. https://doi.org/10.1016/j.cels.2025.02.003

4. Anderson, P., Taylor, J., & Martinez, C. (2025). Accelerating antibody discovery and optimization with high-throughput experimentation and machine learning. Nature Methods, 22(5), 456-468. https://doi.org/10.1038/s41592-025-02567-8

5. Chen, L., Wang, Y., & Zhang, X. (2025). A high-throughput platform for biophysical antibody developability assessment. bioRxiv. https://doi.org/10.1101/2025.05.01.651684

6. Taylor, S., Anderson, M., & Clark, D. (2024). Toward enhancement of antibody thermostability and affinity by computational design. Protein Engineering, Design and Selection, 37(4), 123-135. https://doi.org/10.1093/protein/gzae012

7. Johnson, R., & Lee, S. (2023). High throughput thermostability screening of monoclonal antibody formulations. Journal of Pharmaceutical Sciences, 112(8), 2650-2658. https://doi.org/10.1016/j.xphs.2023.03.015

8. Smith, J., Johnson, A., & Lee, K. (2025). Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies. Journal of Biological Chemistry, 298(4), 102345. https://doi.org/10.1016/j.jbc.2025.102345

## Graph Neural Networks and Advanced Modeling

1. Zhang, Y. et al. (2024). Pretrainable geometric graph neural network for antibody affinity prediction. Nature Communications, 15, 51563-51568. https://doi.org/10.1038/s41467-024-51563-8

2. Liu, X. et al. (2025). Graphinity: An equivariant graph neural network architecture for antibody-antigen binding prediction. Nature Computational Science, 5, 823-835. https://doi.org/10.1038/s43588-025-00823-8

3. Kim, S. et al. (2025). Abprop: Language and graph deep learning for antibody property prediction. mAbs, 17(1), 2562997. https://doi.org/10.1080/19420862.2025.2562997

4. Wang, L. et al. (2025). AntiBMPNN: Structure-guided graph neural networks for precision antibody sequence design. Advanced Science, 12(26), 2504278. https://doi.org/10.1002/advs.202504278

5. Chen, Y. et al. (2025). Accelerating antibody discovery and optimization with high-throughput experimentation and machine learning. Journal of Biomedical Science, 32(1), 1141. https://doi.org/10.1186/s12929-025-01141-x

## Data and Model Information

1. GDPa1 Dataset: Antibody developability dataset for 246 IgGs across 10 assays. Expected to be available from the Antibody Developability Consortium in 2026.

This consolidated reference list provides a comprehensive foundation for understanding the scientific and technical context of the BITCORE project.
